---
title: Prof. Lin Shen Explains Immunotherapy | Understanding Cellular Immunotherapy
url: "https://www.yyhmedical.com/en/news/shen-lin-immunology-cell-immunotherapy-explained"
type: Article
inLanguage: en-US
category: Expert Insights
datePublished: 2026-03-27
---

# Prof. Lin Shen Explains Immunotherapy | Understanding Cellular Immunotherapy

> hrough a doctor-patient conversation, Prof. Lin Shen explains how cellular immunotherapy works, how CAR-T cells recognize and attack cancer, and how treatment-specific side effects such as cytokine release syndrome can be identified and managed.

Summary: In a conversational Q&A, Prof. Lin Shen walks patients and families through the principles and key features of cellular immunotherapy. The discussion explains how immune cells attack cancer, how CAR-T therapy uses engineered T cells to more precisely recognize tumor cells, and how treatment-specific side effects such as cytokine release syndrome (CRS) are recognized and managed. The goal is to help patients better understand how cellular immunotherapy differs from conventional chemotherapy and make more informed treatment decisions.

Oncologists hear many questions from patients and families every day: “What is cancer immunotherapy?” “How is immunotherapy different from chemotherapy?” “How does immunotherapy kill cancer cells?” These questions show that many people still have uncertainties about immunotherapy - and that patients and families often share the same concerns.

We grouped together the questions patients ask most often, drew on the frontline experience of oncology doctors and nurses, and also listened to feedback from patients and families. The aim is to explain the issues people care about most in clear, easy-to-understand language.

Patient: Doctor, you mentioned cellular immunotherapy to me yesterday. I still don't really understand it, so I brought my child with me today. Could you explain it to us in a little more detail?

Prof. Lin Shen: Of course. Please, have a seat. Mr. Liu, as you know, we've already tried most of the treatment options currently available for your condition, but the tumor is still growing. So the next option we're considering is cellular immunotherapy.

Patient: I understand. But what exactly is cellular immunotherapy?

Prof. Lin Shen: Our bodies naturally contain immune cells. You can think of them as the body's security guards. Under normal circumstances, they recognize and attack invading bacteria and viruses - and they can also attack cancer cells.

Patient: Then why does my tumor keep growing?

Prof. Lin Shen: Cancer cells are very good at escaping the immune system. They can disguise themselves, send misleading signals, or suppress immune-cell function. This allows them to evade immune attack, continue multiplying, and drive tumor growth.

Patient: If cancer cells are that good at escaping, can cellular immunotherapy still work?

Prof. Lin Shen: Cellular immunotherapy involves collecting immune cells from the patient and processing and expanding them outside the body. The goal is both to restore or strengthen their ability to attack cancer and to increase their numbers. The cells are then infused back into the patient so they can target tumor cells.

Patient: I think I understand the idea. It sounds reasonable - but how well does it actually work?

Prof. Lin Shen: What I've described so far is the principle behind the treatment. Many forms of cellular immunotherapy are still being studied in clinical trials. In June 2021, China's first approved cellular immunotherapy product entered the market.

Patient: Doctor, I have one more question. I hope you don't mind me asking. A few years ago, there was a young man in the news who also received something called cellular immunotherapy. He spent a lot of money, but it didn't seem to help at all. How is that different?

Prof. Lin Shen: There are many different immune-cell approaches, including dendritic cells (DCs), cytokine-induced killer (CIK) cells, DC/CIK therapy, chimeric antigen receptor T-cell (CAR-T) therapy, and T-cell receptor-engineered T-cell (TCR-T) therapy. These technologies have continued to evolve, and some have become considerably more mature in recent years.

Patient: In my case, which type of cellular immunotherapy would you recommend?

Prof. Lin Shen: We would recommend CAR-T therapy.

Patient: What makes this treatment different?

Prof. Lin Shen: First, CAR-T therapy modifies your own T cells - not dendritic cells (DCs) or cytokine-induced killer (CIK) cells. T cells are powerful immune cells and can mount a strong attack against cancer cells.

Second, in the laboratory, genetic engineering is used to give the T cells a chimeric antigen receptor, or CAR. You can think of the CAR as a highly specific navigation system that helps guide the T cells toward a particular target on cancer cells.

Third, these engineered T cells are stimulated and expanded in large numbers outside the body, and then infused back into the patient to attack the tumor.

Patient: Once the T cells have been modified, can they cause side effects? Will it feel like chemotherapy?

Prof. Lin Shen: The side-effect profile is different from chemotherapy. CAR-T therapy does not typically cause the same pattern of nausea, vomiting, fatigue, and bone marrow suppression associated with chemotherapy. However, when the T cells become highly activated and attack tumor cells, they can release large amounts of cytokines. This can lead to treatment-specific reactions such as fever, low blood pressure, and low oxygen levels.

Patient: I see. Thank you for explaining it. We'll think it over before making a decision.

*Getting Ready to Begin Cellular Immunotherapy*

Prof. Lin Shen: Mr. Liu, we've completed all the preparation for your cellular immunotherapy. Your cells will be infused tomorrow. How are you feeling - ready to go?

Patient: Doctor, what is there to prepare for? I've already been through some very tough chemotherapy. Surely this can't be harder than that?

Prof. Lin Shen: Mr. Liu, cellular immunotherapy works very differently from chemotherapy, so the reactions we watch for are also different.

Patient: I know they're different treatments, but aren't they both trying to kill the tumor? I assumed the side effects would be similar.

Prof. Lin Shen: Not exactly. Chemotherapy mainly relies on the cytotoxic effects of drugs to damage cancer cells. Cellular immunotherapy uses immune cells that originally came from your own body. It generally does not produce the same pattern of nausea, vomiting, or bone marrow suppression seen with chemotherapy.

Patient: So does that mean it's much safer and easier to tolerate? What reactions should I expect most?

Prof. Lin Shen: Fever is one of the most common reactions. It's one of the ways the immune system signals that it is highly activated. If the immune response becomes too intense, the fever can be persistent and high, and in more severe cases blood pressure and oxygen levels can fall. This is called cytokine release syndrome, or CRS.

Patient: How often do these reactions happen?

Prof. Lin Shen: Fever is very common. Low blood pressure and low oxygen levels are less common, and when they do occur, they can usually be managed with medication and supportive care. Other reactions can also occur, but most are relatively mild.

Patient: That's reassuring. What other side effects can happen?

Prof. Lin Shen: The rise in cytokines can also increase the permeability of normal blood vessels, allowing fluid to leak into surrounding soft tissues and cause swelling. A small number of patients may also develop effects involving the central nervous system.

Patient: Central nervous system effects? What can those look like?

Prof. Lin Shen: They can present in different ways, including difficulty speaking clearly, drowsiness, changes in consciousness, impaired thinking or cognition, reduced movement or weakness, and, in severe cases, brain swelling or seizures.

Patient: If a severe reaction does happen, can it be treated?

Prof. Lin Shen: Yes. With prompt and appropriate management, most of these reactions can be controlled effectively. In most cases, they are reversible.

Patient: That's good to know. Thank you, doctor. I feel much more reassured after hearing your explanation, and I'll work closely with the medical team throughout treatment.

---
Original (HTML):https://www.yyhmedical.com/en/news/shen-lin-immunology-cell-immunotherapy-explained
This is a clean Markdown mirror for large language models; the original page is authoritative.